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Abstract Exogenous sphingomyelin, radiolabelled at the sphingosine moiety, was administered to primary cultures of cerebellar granule cells and 
astrocytes for different pulse times (20 min-2 h) and the fate of the radioactivity was followed. Ceramide was the main metabolic product in both 
cells, whereas sphingosine, glucosyl-ceramide and gangliosides GM3 and GD3 were produced only in astrocytes. When endocytosis was prevented 
and the lysosomal apparatus inactivated, ceramide formation was reduced slightly in granule cells and almost completely blocked in astrocytes, with 
disappearance of sphingosine, glucosyl-ceramide, GM3 and GD3. These data indicate that (a) ceramide is rapidly produced in cerebellar granule 
cells and astrocytes, presumably at the level of the plasma membrane in the first cell type, and of the lysosomes in the second one; (b) sphingosine 
is produced in cerebellar astrocytes by lysosomal sphingomyelin degradation and is partly reused for glucosyl-ceramide and ganglioside biosynthesis. 
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1. Introduction 
Sphingomyelin, a major sphingolipid constituent of cell 
membranes in mammals, is preferentially concentrated in the 
outer leaflet of the plasma membrane [l]. In the last few years 
evidence emerged indicating the involvement of sphingomyelin 
degradation in producing sphingoid molecules (ceramide, cer- 
amide-l-phosphate, sphingosine, sphingosine-l-phosphate, 
etc.) with potential second messenger function [2-71. 
Sphingomyelin degradation is initiated by the action of 
sphingomyelinase (SM-ase), with formation of ceramide and 
phosphocholine [2,8]. Both neutral and acidic SM-ases occur 
in different tissues [g-12]. Neutral SM-ases were found in the 
plasma membrane and the cytosol. The plasma membrane as- 
sociated enzyme is Mg”-dependent, particularly abundant in 
the nervous system and enriched in the grey matter [l l-131. In 
cultured neuroblastoma cells it was found to be extracellularly 
oriented [14]. The only known neutral cytosolic SM-ase, puri- 
fied from HL-60 cells, is a Mg”-independent enzyme, activated 
by cell treatment with la,25-dihydroxyvitamin D, [15]. The 
acidic SM-ase appears to be located in the lysosomes [9,10]. 
Both neutral and acidic SM-ases were purified and character- 
ized [l&18] from human and rodent brain. Notwithstanding 
these enzymological studies, little is known on sphingomyelin 
degradation in intact living cells of neural origin. 
Along the research line aimed at ascertaining the possible 
involvement of sphingolipid-mediated signal transduction in 
neural differentiation, we studied the metabolism of sphin- 
gomyelin, with particular attention to the formation of cer- 
amide and sphingosine, in primary cultures of cerebellar neu- 
rons and astrocytes. Both cell lines, obtainable at a high degree 
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of homogeneity, are proper models to study differentiation 
processes in vitro. The cell cultures were exposed to exogenous 
sphingomyelin, radiolabeled at the level of the sphingosine moi- 
ety, and the formation of radioactive metabolites was followed. 
Conditions were used capable to distinguish between the lyso- 
somal and extralysosomal pathway of sphingomyelin degrada- 
tion. The rationale of this approach is based on the evidence 
[19-211 that exogenous phingomyelin is taken up and metabol- 
ically processed by cultured cells, mimicking the behaviour of 
the endogenous compound. 
2. Materials and methods 
2.1. Chemicals 
All reagents were of analytical grade and solvents were redistilled 
before use. Basal modified Eagle’s medium (BME) and FCS (heat 
inactivated before use) were from Flow Laboratories (Irvine, Scotland); 
bovine brain SM, poly-L-lysine, bovine serum albumin and phosphorus 
standard solution from Sigma (St. Louis, MO, USA); [‘H]NaBH, (6.5 
Ci/mmol) from Amersham International (Amersham, Bucks, UK). SM 
was isotopically radiolabelled at the level of the sphingosine moiety 
([Sph-‘HISM), as previously described [22]. Its specific radioactivity 
was 0.35 Ci/mmol, and the radiochemical purity, assessed by HPTLC 
and autoradioscanning, better than 98%. Standard [SH]Cer, [‘H]Sph, 
[SH]Glc-Cer and [‘Hlgangliosides (GM3, GM2, GMl, GDla, GDlb, 
and GTI b) were obtained as previously reported [23-241. 
2.2. Cell cultures 
Primary cultures of granule cells and astrocytes were prepared from 
the cerebellum of 8-day-old rats and cultured as previously described 
125-271. Both cells were plated on 60-mm diameter poly-L-lysine coated 
dishes-and cultured in BME containing 10% FCS: Gianuie cells were 
used at the 8th DIC, when they were fullv differentiated 1251. and . -, 
astrocytes at the lOth-12th DIC, when type I cells prevailed and neu- 
rons were absent [27]. In the used cultures, both types of cells repre- 
sented about 95% of the cell population. Unless otherwise stated, cells 
were grown in a humidified 5% CO, incubator at 37°C. 
2.3. Treatment of cultured cells with [Sph-3H]SM 
Radioactive SM was dissolved in a small volume of absolute thanol 
and mixed with sterile culture medium without FCS at the final concen- 
tration of 2 x 10m6 M (0.7 @X/ml). At the time of experiment, dishes 
were washed three times with temperature conditioned BME without 
FCS and incubated for different periods of time (pulse) (up to 2 h) in 
the same medium (2 ml/dish) containing [Sph-‘H]SM. Treatment with 
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[Sph-‘H]SM was performed in the absence of fetal calf serum in agree- 
ment with previous experience [23,24] and the recent report [28] indicat- 
ing that under this condition taken up SM is able to undergo both the 
lysosomal and extralysosomal processing pathways. The culture me- 
dium was then removed and the cells washed, first with the above 
culture medium containing 10% FCS in order to remove loosely bound 
radioactivity, and then with phosphate-buffered saline (three times). 
Cells were then harvested by scraping, lyophilised and stored at -20°C. 
The process of endocytosis was blocked by performing treatment at 
4°C and lysosomal activity inhibited by adding 1OOyM chloroquine 1 h 
prior and during pulse [24]. 
2.4. Lipid extraction and purification 
Total lipids were extracted and partitioned as previously described 
[24]. The obtained aqueous and organic (this one after a mild alkaline 
hydrolysis) phases were counted for radioactivity and analyzed for 
individual constituents (see below). The recognition and identification 
of the individual [‘Hlmetabolites (Cer, Glc-Cer, Sph and individual 
gangliosides) was performed as described [23,24]. 
2.5. Lipid separation by HPTLC 
The different lipids present in the organic and aqueous phases were 
separated by HPTLC, using chloroform/methanol/water (55 : 20: 3, by 
vol.) or chloroformlmethanol/32% NH,OH (40 : 10 : 1, by vol.), for the 
organic phase and chloroform/methanol/0.2% CaCI, (55 : 45 : 10, by 
vol.) for the aqueous phase. After HPTLC, the plates were radio- 
scanned with a digital autoradiograph (Berthold, Germany). 
2.6. Calorimetric methods 
SM was determined, after perchloric acid digestion, according to the 
procedure of Bartlett [29], as modified by Dodge and Phillips [30]. Total 
proteins were assayed [31] using bovine serum albumin as the standard. 
3. Results 
As shown in Fig. 1, the uptake of [Sph-3H]SM by cultured 
granule cells and astrocytes was time-dependent in the 20-60 
min pulse period examined. Both cell types incorporated similar 
amounts of radioactivity, astrocytes showing a slightly higher 
uptake. At all investigated times and in both cell types, radiola- 
belled SM accounted for the large majority of incorporated 
radioactivity (> 85%). After 60 min pulse the amount of bound 
[Sph-‘H]SM accounted for about 5.4 and 3.5% of the en- 
dogenous SM in granule cells and astrocytes, respectively. 
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Fig. 1. Time course of stable radioactivity incorporation into cerebellar 
granule cells and astrocytes in culture, after exposure to 2 x 10m6 M
[Sph-‘H]SM for different periods of time. The data presented are the 
mean f S.D. of three experiments and are expressed as nCi/mg protein. 
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Fig. 2. Incorporation of radioactivity into Cer and Sph by cerebellar 
granule cells-and astrocytes in cult&e after exposure to2 x IO-” M 
I&h-‘HlSM for different pulse times. The data nresented are the mean -- _ 
of three experiments and are expressed as nCi/mg protein. S.D. values 
never exceeded 12% of the mean values. 
In both granule cells and astrocytes [3H]Cer was the major 
metabolite from exogenous SM. As shown in Fig. 2a, it was 
produced early (already at 20 min) after exposure, in a time- 
dependent fashion, and in higher amounts by neurons than 
astrocytes. In cultured astrocytes [3H]Sph started being measur- 
able after a 30 min pulse (Fig. 2b), its content increasing with 
time but being always 25- to 30-fold lower than that of [“H]Crr. 
Conversely, no [3H]Sph could be detected in cultured granule 
cells up to 2 h. The subcellular site of formation of sphingaid 
metabolites from exogenous SM was inspected with esperi- 
ments carried out at 4°C or in the presence of 100 ,uM chloro- 
quine using a pulse of 2 h. The results, shown in Fig. 3. demon- 
strate that both conditions affected the formation of radiola- 
belled sphingoid molecules only partially in granule cells but 
very markedly in astrocytes. In particular, the radioactivity 
incorporated into Cer (as percent of the control cells) was 83% 
and 10% in the presence of chloroquine, and 60% and 1.5% at 
4”C, in granule cells and astrocytes, respectively. In astrocytes 
the formation of [3H]Sph was completely blocked in both exper- 
imental conditions. After a 2-h pulse at 37”C, also radiolabelled 
glycosphingolipids (mainly [3H]Glc-Cer and [3H]gangliosides) 
were produced by cultured astrocytes but not by neurons (Fig. 
4). The formed [3H]gangliosides were GM3 (92%) and GD3 
(8%), the major gangliosides of astrocytes. In the presence of 
100pM chloroquine and at 4°C these molecules were undetect- 
able in both cells. 
4. Discussion 
The first evidence provided by this work is that primary 
cultures of neurons (granule cells) and astrocytes from rat cer- 
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ebellum, are capable to rapidly take up and promptly metabo- 
lize exogenous SM. Within a 60 min period of pulse, Cer ap- 
peared to be the main metabolite of exogenous SM in both cell 
types, was produced at an higher rate by granule cells than 
astrocytes and started being formed early (20 min, possibly less) 
after exposure to exogenous SM. The formation of ceramide 
was differently affected in the two cell types by conditions 
blocking endocytosis or inhibiting lysosomal enzymes activi- 
ties. In fact, the diminution of formed cer caused by these 
conditions was only partial (40-17% as percent of controls) in 
granule cells but almost complete (98590%) in astrocytes. 
This leads to conclude that the first step of SM degradation 
occurs essentially at an extralysosomal site (presumably via the 
plasma membrane-bound SM-ase) in granule cells, and in- 
tralysosomally (presumably by the acidic SM-ase) in astrocytes. 
This interpretation may reflect the fact that the plasma mem- 
brane-bound SM-ase is abundant in cultured neurons but ab- 
sent in glial cells [32]. It would be interesting to assess whether 
a cytosolic SM-ase occurs in granule cells and concurs to SM 
degradation. 
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A further information is that, at the used pulse-times, astro- 
cytes produce Sph from exogenous SM, whereas granule cells 
do not. In astrocytes Sph formation implies endocytosis and 
lysosomal processing, since it is completely blocked by incuba- 
tion at 4°C and chloroquine treatment. A likely explanation for 
the absence of Sph formation in granule cells is that in these 
cells the endocytosis-degradation route of SM is scarce and Cer 
produced at the plasma membrane level does not reach the 
lysosomes thus avoiding further degradation, at least in the 
examined period of time. It is surprising that under identical 
experimental conditions granule cells are able to internalize, via 
endocytosis, and submit to lysosomal degradation taken up 
exogenous ganglioside [24], with formation of both Cer and 
Sph. This may indicate that, after endocytosis, taken up SM is 
Fig. 4. Incorporation of radioactivity into Glc-Cer and gangliosides by 
cerebellar granule cells and astrocytes after a 2-h pulse with 2 x 10m6 M
[Sph-‘H]SM at 37°C 4°C or at 37°C in the presence of 100 PM chlo- 
roquine. The data presented are the mean of three experiments and are 
expressed as % of incorporated radioactivity referred to controls. S.D. 
values never exceeded 15% of the mean values. 
mainly recycled back to the plasma membrane [4,33], whereas 
ganglioside is sorted to the lysosomal apparatus. 
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A final result deserving comment is the formation of glyco- 
sphingolipids from exogenous SM metabolism. This event oc- 
curs in astrocytes but not in neurons. Under the used experi- 
mental conditions glycosphingolipids can be biosynthesized 
starting from a fragment of SM degradation (Sph, Cer) which 
escapes further degradation and is reused for biosynthetic pur- 
poses at the Golgi apparatus level [23]. In astrocytes, where SM 
degradation occurs in the lysosomes, the Sph (and/or Cer) 
produced in the lysosomes erve(s) as the precursor(s). In gran- 
ule cells, where SM degradation likely takes place in the plasma 
membrane, formed Cer cannot be easily available at the site of 
glycosphingolipid biosynthesis. 
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Fig. 3. Incorporation of radioactivity into Cer and Sph by cerebel- 
lar granule cells and astrocytes after a 2-h pulse with 2 x 10e6 M 
[Sph-jH]SM at 37”C, 4°C or at 37°C in the presence of 100 PM 
chloroquine. The data presented are the mean of three experiments and 
are expressed as % of incorporated radioactivity referred to controls. 
S.D. values never exceeded 15% of the mean values. 
In conclusion, this work demonstrates that primary cultures 
of neurons and astrocytes are capable to produce bioactive 
sphingoids from exogenous sphingomyelin, although through 
different pathways. In both cell types the formation of sphin- 
goid bioregulators is a relatively rapid process. Therefore, the 
cellular models presented here appear to be suitable to study 
the possible implication of sphingolipid-mediated signal 
transduction in neural functional events, particularly differen- 
tiation. 
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